Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 18;24(1):1347.
doi: 10.1186/s12889-024-18848-5.

Cognition as mediator of pulmonary function and risk of sarcopenia among older adults

Affiliations

Cognition as mediator of pulmonary function and risk of sarcopenia among older adults

Zhao Hu et al. BMC Public Health. .

Abstract

Background: The relationship between lung function and sarcopenia remains ambiguous. The primary aim of this study was to investigate the potential association between lung function and sarcopenia in the older adults, as well as to examine the mediating role of cognitive function in this relationship.

Methods: The participants were selected from a nationally representative population-based cohort in China. The peak expiratory flow (PEF) measurement was used to evaluate the lung function in older persons. The sarcopenia was diagnosed using the guidelines of the Asian Working Group for Sarcopenia (AWGS) in 2019. The Cox proportional hazard model was utilized to perform primary analyses of the relationship between PEF and sarcopenia. The mediating effect of cognitive function was evaluated using the counterfactual mediation method.

Results: This cohort study included 4,011 older adults (average age, 66.6 years; 53.3% males). During a follow-up period of 3.86 years, 349 individuals were diagnosed with sarcopenia. After adjusting for potential confounders, each one-standard-deviation increase in PEF was associated with a 28% reduction in the risk of sarcopenia (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.63, 0.80). There was a significant mediation of cognition for the association between PEF and incident sarcopenia, and the proportion mediated was 12.2% (95% CI: 4.5%, 23.1%).

Conclusions: Older adults with impaired lung function are more likely to develop sarcopenia. Nevertheless, cognition can explain only a small portion of this association. Thus, other potential pathways between lung function and sarcopenia must be elucidated.

Keywords: Cognition; Cohort; Lung function; Mediation; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Cognitive function acts as a mediator in the relationship between lung function indicators and sarcopenia. Panel A: Cognitive function as a mediator for the association between PEF and sarcopenia. Panel B: Cognitive function as a mediator for the association between PEFR and sarcopenia Note: The association of per SD increment in PEF or PEFR with sarcopenia was fitted using Cox proportional hazard models after adjusting for age, gender, education, marital status, smoking, alcohol consumption, sleep duration, nap duration, hypertension, diabetes, dyslipidemia, chronic lung diseases, cardiovascular disease, and arthritis. The association between PEF or PEFR and cognition function was modeled using generalized linear regression after adjusting for the same covariates, whereas the association of per one SD increment in cognition function (5.6 points) with sarcopenia was modeled using Cox proportional hazard regression was also adjusted for PEF or PEFR PEF, peak expiratory flow; PEFR, peak expiratory flow rate

Similar articles

References

    1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J] Age Ageing. 2019;48(1):16–31. doi: 10.1093/ageing/afy169. - DOI - PMC - PubMed
    1. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and Treatment[J] J Am Med Dir Assoc. 2020;21(3):300–e3072. doi: 10.1016/j.jamda.2019.12.012. - DOI - PubMed
    1. Sayer AA, Syddall H, Martin H, et al. The developmental origins of sarcopenia[J] J Nutr Health Aging. 2008;12(7):427–32. doi: 10.1007/BF02982703. - DOI - PMC - PubMed
    1. Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of Sarcopenia and severe Sarcopenia: a systematic review and meta-analysis[J] J Cachexia Sarcopenia Muscle. 2022;13(1):86–99. doi: 10.1002/jcsm.12783. - DOI - PMC - PubMed
    1. Yuan S, Larsson SC. Epidemiology of Sarcopenia: prevalence, risk factors, and consequences[J] Metabolism. 2023;144:155533. doi: 10.1016/j.metabol.2023.155533. - DOI - PubMed

LinkOut - more resources